How can we improve clinical trials in amyotrophic lateral sclerosis?
about
Dysregulation of the autophagy-endolysosomal system in amyotrophic lateral sclerosis and related motor neuron diseasesCentral Nervous System-Peripheral Immune System Dialogue in Neurological Disorders: Possible Application of Neuroimmunology in UrologyAmyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic TrialsAdvances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative DiseasesInduced Pluripotent Stem Cell Models to Enable In Vitro Models for Screening in the Central Nervous SystemBeing PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?Amyotrophic lateral sclerosis disease progression model.Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration.Experimental Design and Data Analysis Issues Contribute to Inconsistent Results of C-Bouton Changes in Amyotrophic Lateral Sclerosis.Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research.Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole.Amyotrophic lateral sclerosis: update and new developments.Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.Uptake of inorganic mercury by human locus ceruleus and corticomotor neurons: implications for amyotrophic lateral sclerosis.Protein SUMOylation, an emerging pathway in amyotrophic lateral sclerosis.New therapy options for amyotrophic lateral sclerosis.Moving forward in clinical trials for ALS: motor neurons lead the way please.Studying human disease using human neurons.From Reproducibility to Translation in Neurodegenerative Disease.Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection.Outcome measures in amyotrophic lateral sclerosis clinical trialsCharacterization of Wnt/β-catenin and BMP/Smad signaling pathways in an in vitro model of amyotrophic lateral sclerosis.Comparing methods to combine functional loss and mortality in clinical trials for amyotrophic lateral sclerosis.A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis
P2860
Q21285051-89213014-536D-4452-A202-1F8E2AD85FFEQ26745684-14E0021F-4945-4A03-926C-F24D1D8A5DEBQ27021917-3A308B41-83D5-4937-A319-D63B57765EEFQ28067160-AC31C2BC-CDFF-49CF-A08A-7683F6EBB3A0Q28082668-BC7B4169-348B-4DCD-9A6C-E3B813E11FD2Q28649394-56471FF9-4429-44B7-BD53-7C843B5D94EDQ30486384-B295393D-EC2A-4D7A-A4DB-F22AFFD13A30Q30659873-491563DA-BACD-4BD4-B088-0417EEE83205Q31155328-D3898232-3E67-4576-99AE-432245EE56B5Q34401653-0E44425D-918E-4654-BF62-6624BD9F71DCQ36202825-63391FAB-A14B-45CC-96B8-9D371A668F4DQ36278310-4DF0C08A-11E4-4102-8FBB-8D4A38DF9ADEQ37451385-210B4F5A-E317-4D12-9459-9D335D31326DQ37485669-585FA11A-C183-4EC6-B4B2-BB349CFF051FQ38071685-DD214991-BBC5-4E08-9ABC-1596F00658B9Q38121637-D1DC8633-E952-492C-A81B-73D78D7EB23FQ38156505-DFD99250-894D-4852-8341-9CE276939CEEQ38802823-AA63F0E9-A744-4866-A06F-CEB2DB2A910AQ38819341-3BA7C6F0-F89B-49C5-8D59-4BAF7EDBBF3DQ38847200-FAAE2D34-EF20-42D1-9B99-680E8DF3B868Q41837997-2B8AB0D1-A367-4A97-9B42-C11D6EB68903Q42853712-067FF0C2-9C83-4FCA-A52A-E19F6E9F6C06Q51733178-590A3943-B8D8-4D0E-A0AC-F8AABABF7656Q57666978-D16635A0-62F8-4B35-A389-CFD81F315D81
P2860
How can we improve clinical trials in amyotrophic lateral sclerosis?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
How can we improve clinical trials in amyotrophic lateral sclerosis?
@en
How can we improve clinical trials in amyotrophic lateral sclerosis?
@nl
type
label
How can we improve clinical trials in amyotrophic lateral sclerosis?
@en
How can we improve clinical trials in amyotrophic lateral sclerosis?
@nl
prefLabel
How can we improve clinical trials in amyotrophic lateral sclerosis?
@en
How can we improve clinical trials in amyotrophic lateral sclerosis?
@nl
P2860
P1476
How can we improve clinical trials in amyotrophic lateral sclerosis?
@en
P2860
P2888
P304
P356
10.1038/NRNEUROL.2011.147
P407
P577
2011-09-27T00:00:00Z